KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Cash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Net Income (2016 - 2025)

Historic Net Income for TherapeuticsMD (TXMD) over the last 16 years, with Q3 2025 value amounting to $102000.0.

  • TherapeuticsMD's Net Income rose 34285.71% to $102000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $229000.0, marking a year-over-year decrease of 6482.33%. This contributed to the annual value of $131000.0 for FY2024, which is 10507.95% up from last year.
  • As of Q3 2025, TherapeuticsMD's Net Income stood at $102000.0, which was up 34285.71% from $6000.0 recorded in Q2 2025.
  • TherapeuticsMD's Net Income's 5-year high stood at $127.2 million during Q2 2022, with a 5-year trough of -$47.4 million in Q3 2021.
  • Its 5-year average for Net Income is $1.6 million, with a median of -$28500.0 in 2024.
  • Its Net Income has fluctuated over the past 5 years, first skyrocketed by 39811.97% in 2022, then plummeted by 12266.67% in 2025.
  • TherapeuticsMD's Net Income (Quarter) stood at $50.2 million in 2021, then crashed by 41.68% to $29.2 million in 2022, then plummeted by 97.75% to $658000.0 in 2023, then tumbled by 79.03% to $138000.0 in 2024, then dropped by 26.09% to $102000.0 in 2025.
  • Its last three reported values are $102000.0 in Q3 2025, $6000.0 for Q2 2025, and -$17000.0 during Q1 2025.